Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant.
Publication
, Journal Article
Mehta, B; Mahadeo, K; Zaw, R; Tang, S; Kapoor, N; Abdel-Azim, H
Published in: Pediatr Blood Cancer
December 2014
Duke Scholars
Published In
Pediatr Blood Cancer
DOI
EISSN
1545-5017
Publication Date
December 2014
Volume
61
Issue
12
Start / End Page
2324 / 2325
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Severe Combined Immunodeficiency
- Pyrazines
- Prognosis
- Oncology & Carcinogenesis
- Male
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Bortezomib
Citation
APA
Chicago
ICMJE
MLA
NLM
Mehta, B., Mahadeo, K., Zaw, R., Tang, S., Kapoor, N., & Abdel-Azim, H. (2014). Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant. Pediatr Blood Cancer, 61(12), 2324–2325. https://doi.org/10.1002/pbc.25172
Mehta, Bhakti, Kris Mahadeo, Re Zaw, Shinyi Tang, Neena Kapoor, and Hisham Abdel-Azim. “Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant.” Pediatr Blood Cancer 61, no. 12 (December 2014): 2324–25. https://doi.org/10.1002/pbc.25172.
Mehta B, Mahadeo K, Zaw R, Tang S, Kapoor N, Abdel-Azim H. Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant. Pediatr Blood Cancer. 2014 Dec;61(12):2324–5.
Mehta, Bhakti, et al. “Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant.” Pediatr Blood Cancer, vol. 61, no. 12, Dec. 2014, pp. 2324–25. Pubmed, doi:10.1002/pbc.25172.
Mehta B, Mahadeo K, Zaw R, Tang S, Kapoor N, Abdel-Azim H. Bortezomib for effective treatment of a child with refractory autoimmune hemolytic anemia post allogeneic hematopoietic stem cell transplant. Pediatr Blood Cancer. 2014 Dec;61(12):2324–2325.
Published In
Pediatr Blood Cancer
DOI
EISSN
1545-5017
Publication Date
December 2014
Volume
61
Issue
12
Start / End Page
2324 / 2325
Location
United States
Related Subject Headings
- Transplantation, Homologous
- Severe Combined Immunodeficiency
- Pyrazines
- Prognosis
- Oncology & Carcinogenesis
- Male
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Bortezomib